HALF MOON BAY, Calif., Nov. 19, 2013 (GLOBE NEWSWIRE) -- Endeavor IP, Inc. (OTCBB:ENIP), an intellectual property services and patent licensing company, announced today that it has been issued a Notice of Allowance from the United States Patent and Trademark Office ("USPTO"). The Notice of Allowance pertains to its wholly-owned subsidiary Endeavor MeshTech, Inc. and the patent titled Wireless Communication Enabled Meter and Network.
Endeavor IP, Inc.'s wholly-owned subsidiary Endeavor MeshTech, Inc. has filed patent infringement lawsuits against four defendants to-date in regards to its Wireless Communication Enabled Meter and Network patent.
Endeavor IP, Inc. continues to explore opportunities to vigorously prosecute its patent portfolio. The law firm representing Endeavor IP, Inc. in the prosecution of this patent is Lowenstein Sandler LLP.
Cameron Gray, Chief Executive Officer of Endeavor IP, Inc. said, "We are very pleased with this addition to Endeavor MeshTech, Inc.'s patent portfolio. The portfolio has been licensed by four companies to-date and there are four pending patent infringement lawsuits against four additional companies. This Notice of Allowance increases the portfolios to two issued U.S. patents and one allowed U.S. patent, which we anticipate issuing in the coming months."
Endeavor IP, Inc.
Endeavor IP, Inc. is an intellectual property services and patent licensing company that is engaged in the acquisition and licensing of intellectual property. Endeavor is based in Half Moon Bay, CA. http://www.enip.com.
Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), not limited to Risk Factors relating to its patent business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.
CONTACT: Stephen Hart Hayden IR email@example.com 917-658-7878
|Voip-Pal.com’s Enhanced 911 and Routing, Billing and Rating Patents Have Been Issued by the United States Patent and Trademark Office (2013/9/26)|
|Idenix Pharmaceuticals Announces Decision by the United States Patent and Trademark Office Patent Trial and Appeal Board in the First Patent Interference (2014/1/29)|
|Advaxis Receives Notice of Allowance From U.S. Patent and Trademark Office for Three Patent Applications With Multiple Claims Covering Its Cancer Immunotherapy Platform Technology (2014/4/1)|
|United States Patent & Trademark Office Issues First New Notice of Allowance to Spherix on Rockstar Data Network Patent Application Since Closing of Acquisition from Rockstar (2014/2/20)|
|Endeavor IP, Inc.'s Subsidiary, Endeavor Energy, Inc.'s Patent Litigation Against Con Edison Solutions Included In The Federal Patent Pilot Program. (2013/9/19)|
|BrainStorm Receives United States Patent Office Notice of Allowance for Its Stem Cell Technology (2014/1/13)|
|Endeavor IP, Inc.'s Wholly-Owned Subsidiary, Endeavor Meshtech, Inc. Has Filed Additional Patent Infringement Lawsuits Against Two Defendants ()|
|Endeavor IP, Inc.'s Wholly-Owned Subsidiary, Endeavor Energy, Inc., Has Filed a Patent Infringement Lawsuit Against Tucson Electric Power Company (2014/1/9)|
|8x8 Issued New Communications Patent by U.S. Patent and Trademark Office (2013/9/11)|
|BioLineRx Announces Receipt of a Notice of Allowance from USPTO for Patent on Use of BL-8020, an Oral, Interferon-Free Treatment for Hepatitis C ()|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.